Foundayo vs Zepbound: The Honest Comparison (Pill vs Shot, 2026)
By WPG Research Team · Published · Last verified:
We may earn a commission from some links on this page. Our rankings reflect our methodology, not affiliate payouts. We do not promote compounded medications on FDA-approved brand-name comparison pages.
Medical note: This is educational and not medical advice. Do not start, stop, or switch a prescription medication without a licensed clinician.
Foundayo vs Zepbound comes down to one tradeoff: more weight loss, or less hassle. Zepbound is a once-weekly injection that produced about 20–22% body weight loss at the top dose in clinical trials. Foundayo is a once-daily pill that produced about 11–12% at the top dose. Both are made by Eli Lilly. Both are FDA-approved. Cash prices through LillyDirect start at $149/month (Foundayo) and $299/month (Zepbound).
Foundayo vs Zepbound at a Glance
Sources: FDA approval announcements; Lilly ATTAIN-1 and SURMOUNT-1 trial releases; LillyDirect pricing pages — verified May 13, 2026
| Foundayo | Zepbound | |
|---|---|---|
| Type | Daily oral pill | Weekly subcutaneous injection |
| Active ingredient | Orforglipron | Tirzepatide |
| Maker | Eli Lilly | Eli Lilly |
| FDA approved | April 1, 2026 | November 8, 2023 |
| How it works | GLP-1 only (non-peptide small molecule) | Dual GIP + GLP-1 agonist |
| Average top-dose weight loss | 11.1% (treatment-regimen) / 12.4% (completers) — ATTAIN-1, 72 weeks | 20.9% (treatment-regimen) / 22.5% (efficacy) — SURMOUNT-1, 72 weeks |
| Cash price (LillyDirect) | $149–$349/month | $299–$699/month ($449 with Self Pay Journey at higher doses) |
| With insurance + savings card | As low as $25/fill for eligible commercially insured patients | As low as $25/fill for eligible commercially insured patients |
| Refrigeration needed | No (room temperature, 68–77°F) | Yes (with some room-temperature flexibility) |
| Food or water timing rules | None — any time, any meal, any beverage | N/A (injection) |
| FDA-approved for sleep apnea | No | Yes — moderate to severe OSA in adults with obesity |
| Boxed warning | Thyroid C-cell tumors | Thyroid C-cell tumors |
| Best-fit reader | Needle-free start, lower monthly cash ceiling, travel/storage simplicity, maintenance after another GLP-1 | Maximum average weight loss, OSA indication, comfortable with weekly injections |
Check your coverage before you decide
If you have commercial insurance, your real cost for either drug could be $25 per fill — or it could be $300+ per month. The only way to know is to check. Ro carries Foundayo, Zepbound KwikPen, and Zepbound vials. Ro's free GLP-1 Insurance Coverage Checker creates a personalized coverage report. Get started for $39, then as low as $74/month with annual plan paid upfront. Medication cost is separate.
Check Foundayo or Zepbound Options with RoIs Foundayo the Pill Version of Zepbound?
Short answer: No.
This is the most common assumption people bring to this comparison, and it's worth correcting up front because it changes everything else. Here's why the difference matters:
Tirzepatide (Zepbound)
Activates both GIP and GLP-1 receptors simultaneously. Two pathways pulling on appetite, blood sugar, and metabolism. That's why the weight loss numbers are higher. Requires injection — peptide drugs are broken down by stomach acid.
Orforglipron (Foundayo)
A small-molecule, non-peptide drug — chemically built rather than biologically grown. Survives stomach acid (so it can be a pill), taken any time with or without food, stored at room temperature. No 30-minute morning fast. No cold-chain shipping. GLP-1 only.
How Much Weight Will You Actually Lose on Each?
Answer: At the highest approved doses, Zepbound users lost an average of 20.9–22.5% of body weight in SURMOUNT-1. Foundayo users lost an average of 11.1–12.4% in ATTAIN-1. For a 230-pound person, that's roughly 47 pounds on Zepbound vs 27 pounds on Foundayo, both over about 72 weeks. There has been no head-to-head trial comparing the two drugs directly.
Foundayo (ATTAIN-1, 72 weeks, adults without diabetes)
| Dose | Average weight loss | Pounds lost (avg starting weight ~227 lb) |
|---|---|---|
| 5.5 mg | 7.4% | ~17 lb |
| 9 mg | 8.3% | ~19 lb |
| 17.2 mg | 11.1% (treatment-regimen) / 12.4% (completers) | ~25–27 lb |
| Placebo | 2.1% | ~5 lb |
Sources: Lilly ATTAIN-1 press release; Foundayo prescribing information.
Zepbound (SURMOUNT-1, 72 weeks, adults without diabetes)
| Dose | Average weight loss |
|---|---|
| 5 mg | ~15% |
| 10 mg | ~19.5% |
| 15 mg | 20.9% (treatment-regimen) / 22.5% (efficacy) |
| Placebo | ~3.1% |
In the more recent SURMOUNT-5 head-to-head trial, Zepbound produced 20.2% mean weight loss compared with 13.7% for Wegovy at 72 weeks. That's Zepbound vs Wegovy, not Zepbound vs Foundayo — but it's the strongest available evidence that Zepbound is currently the most effective FDA-approved weight loss drug on the market.
Source: Lilly SURMOUNT-5 investor release.
Our honest take on the efficacy gap
If your top priority is the biggest possible weight loss, Zepbound is the better choice. Foundayo is not as strong on average. We're telling you that plainly because you'd find out anyway.
But the efficacy gap doesn't capture what matters in real life: the most effective drug is the one you actually take. A 22% loss on paper means nothing if you stop weekly injections after three months because needles aren't for you. An 11% loss you achieve beats a 22% loss you walk away from.
11% body weight loss is also not a consolation prize. For a 230-pound person, that's about 25 pounds — and the FDA notes that losing 5–10% of body weight has been associated with reduced cardiovascular disease risk in adults with obesity or overweight. Foundayo's average outcome lands above that threshold.
How Much Does Foundayo vs Zepbound Cost Without Insurance?
Answer: Foundayo costs $149–$349 per 30-day fill cash through LillyDirect. Zepbound costs $299–$699 per 28-day fill, with a flat $449 rate at higher doses through the Self Pay Journey program if you refill on time. With commercial insurance plus a manufacturer savings card, both can drop to $25 per fill — but the savings caps are different.
Foundayo Cash Prices by Dose (LillyDirect, verified May 13, 2026)
A Foundayo "month" is defined as 30 days.
| Foundayo dose | Cash price per 30-day fill |
|---|---|
| 0.8 mg (starter) | $149 |
| 2.5 mg | $199 |
| 5.5 mg | $299 |
| 9 mg | $299 |
| 14.5 mg | $349 standard; $299 with refill within 45 days |
| 17.2 mg | $349 standard; $299 with refill within 45 days |
Source: Foundayo coverage & savings terms, foundayo.lilly.com.
Zepbound Cash Prices by Dose (LillyDirect, verified May 13, 2026)
A Zepbound "month" is defined as 28 days (4 weekly doses).
| Zepbound dose | Cash price per 28-day fill |
|---|---|
| 2.5 mg (starter) | $299 |
| 5 mg | $399 |
| 7.5 mg | $499 standard; $449 with Self Pay Journey |
| 10 mg | $699 standard; $449 with Self Pay Journey |
| 12.5 mg | $699 standard; $449 with Self Pay Journey |
| 15 mg | $699 standard; $449 with Self Pay Journey |
The Self Pay Journey program requires refill within 45 days of your previous delivery. Miss the window, pay standard price.
Source: Zepbound Self Pay terms, lilly.com.
The Annual Cost Math Nobody Puts in One Place
Foundayo is a 30-day fill. Zepbound is a 28-day fill. A full calendar year is 365 days, which works out to about 12 Foundayo fills or about 13 Zepbound fills. Here are two cash-pay models for a 230-pound person at the top dose through LillyDirect.
Model 1: 12 fills (about 360 days of medication)
| Path | 12-fill cost | Trial-reported weight loss (72 weeks) |
|---|---|---|
| Foundayo 17.2 mg (45-day refill) | $3,588 | ~25–27 lb |
| Foundayo 17.2 mg (standard) | $4,188 | ~25–27 lb |
| Zepbound 15 mg (Self Pay Journey) | $5,388 | ~47 lb |
| Zepbound 15 mg (standard) | $8,388 | ~47 lb |
Model 2: 365-day annualized cost
| Path | 365-day cost (approx 13 Zepbound fills, 12 Foundayo fills) |
|---|---|
| Foundayo 17.2 mg (45-day refill) | ~$3,640 |
| Foundayo 17.2 mg (standard) | ~$4,247 |
| Zepbound 15 mg (Self Pay Journey) | ~$5,837 |
| Zepbound 15 mg (standard) | ~$9,087 |
Insurance Savings Cards — The Fine Print
Both Foundayo and Zepbound have manufacturer savings cards for eligible commercially insured patients with a prescription for an approved use. The fine print is different for each.
Foundayo savings card
- • As low as $25 per fill
- • Maximum annual savings: $1,000
- • Maximum fills: 10 per calendar year
- • Expires December 31, 2026
- • Government insurance excluded
Runs out around mid-October if you're filling monthly
Zepbound savings card
- • As low as $25 per fill
- • Maximum annual savings: $1,300
- • Maximum fills: 13 per calendar year
- • Expires December 31, 2026
- • Government insurance excluded
Sized to cover roughly a full year of 28-day fills
Medicare Access Starting July 2026
Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027)
The CMS Medicare GLP-1 Bridge is expected to allow some Medicare Part D plans to cover obesity medications starting July 1, 2026. CMS lists Foundayo, Wegovy injection, Wegovy tablets, and Zepbound KwikPen as eligible drugs. Zepbound single-dose pens and single-dose vials are not included.
Eligibility requires qualifying obesity-related comorbidities. Estimated cost for eligible enrollees: about $50/month.
Provider Fees Stack on Top
The prices above are medication-only. Telehealth providers add a program or membership fee:
| Provider | Program fee | What it covers |
|---|---|---|
| LillyDirect direct | None beyond medication | Drug shipped or picked up — need an existing prescriber |
| Ro | $39 first month, then $149/month or as low as $74/month with annual prepay | Provider visits, dose adjustments, insurance concierge, coaching |
| Sesame Care | $59–$99/month | Video visit with a provider of your choice, ongoing messaging |
Should You Switch From Zepbound to Foundayo?
⚠️ This is the data that should be at the top of every Foundayo vs Zepbound page — and somehow isn't.
The ATTAIN-MAINTAIN Trial, in Plain English
In late 2025 and early 2026, Lilly ran a study called ATTAIN-MAINTAIN. It took people who had already lost meaningful weight on injectable GLP-1s — either Wegovy or Zepbound — and switched them to Foundayo for 52 weeks. The question: can the pill hold on to what the injection achieved?
The answer split by which injection people started on:
| Prior medication | Avg prior weight loss | Avg regain after switching to Foundayo | % of prior loss maintained on Foundayo | % maintained on placebo |
|---|---|---|---|---|
| Wegovy (semaglutide) | 40.7 lb | ~2 lb | 79.3% | 37.6% |
| Zepbound (tirzepatide) | 54.8 lb | ~11 lb | 74.7% | 49.2% |
Source: Reuters, May 12, 2026 — "Patients don't regain much weight switching from injections to Lilly's weight-loss pill."
Two readings of this data, both true:
- Foundayo is dramatically better than stopping treatment. Patients who went to placebo lost a huge chunk of their progress. Patients on Foundayo kept most of theirs.
- The Zepbound→Foundayo switch is harder than the Wegovy→Foundayo switch. Zepbound users gave back more — about 11 pounds on average. Switching drops one of Zepbound's two incretin pathways.
"The reduced price sure makes that tempting, though my shots have been life altering for me so I'm leery about changing course."— r/Zepbound user, Foundayo Maintenance? thread, accessed May 13, 2026
"I honestly prefer once a week over a daily medication, I just want to save money lol."— r/Zepbound user, same thread, accessed May 13, 2026
When switching might still be right:
- • Your insurance is dropping Zepbound coverage
- • You've hit your goal weight and moving into maintenance
- • Injection site reactions or needle anxiety are causing missed doses
- • Refrigeration or travel logistics are real problems
When you should stay put:
- • Zepbound is working and the cost is sustainable
- • You're early or mid-treatment, not at goal yet
- • Your only reason is "Foundayo is new and cheaper"
If insurance is your driver, that's a coverage problem, not necessarily a medication problem. Try the appeal route before changing drugs.
Who Should Pick Foundayo. Who Should Pick Zepbound.
Answer: Pick Zepbound if you want maximum weight loss, have obesity with sleep apnea, or are comfortable with weekly injections. Pick Foundayo if you won't take injections, you travel often, you're cost-sensitive on a monthly basis, or you're transitioning into maintenance after hitting your goal on another GLP-1.
Pick Zepbound if…
You're the "maximum results" person
Your goal is to lose 40+ pounds. You're comfortable with weekly injections. Insurance might cover it, or your budget can handle $449/month at the top doses via Self Pay Journey. The 20%+ average weight loss is the highest in any FDA-approved obesity drug.
You have sleep apnea
Zepbound is the only GLP-1 medication FDA-approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity. Foundayo is not approved for OSA. Wegovy is not approved for OSA. If sleep apnea is part of why you're considering a GLP-1, only Zepbound has FDA backing for that indication.
Pick Foundayo if…
You're the "no needles, period" person
You've never been able to talk yourself into starting an injectable GLP-1. The Wegovy pill's 30-minute morning fasting routine doesn't work for your schedule. Foundayo has none of those barriers — any time of day, with or without food, no fasting, no needles.
You're cash-pay and budget-sensitive
You don't have GLP-1 coverage. Your monthly cost ceiling is under $300. Foundayo starts at $149/month. Zepbound starts at $299/month. Foundayo's top dose with the refill program is $299/month. Zepbound's top dose with Self Pay Journey is $449/month. Over a year, the gap is roughly $1,800–$2,200.
You're moving into maintenance
You've hit your goal weight on another GLP-1. You don't need maximum efficacy — you need something sustainable for years without injection logistics. ATTAIN-MAINTAIN data shows Foundayo maintained roughly 75–79% of prior weight loss in switchers.
⛔ Pick neither without a doctor's evaluation if any of this applies
Hard contraindications on both labels:
- • Personal or family history of medullary thyroid carcinoma (MTC)
- • Multiple endocrine neoplasia syndrome type 2 (MEN 2)
- • Known serious hypersensitivity to the active ingredient or excipients
Clinician-review situations (warnings and precautions — not absolute contraindications):
- • History of pancreatitis or severe gastrointestinal disease / severe gastroparesis
- • Acute or chronic gallbladder disease
- • Pregnancy, planning pregnancy, or breastfeeding
- • Using insulin or sulfonylureas (hypoglycemia risk)
- • Upcoming surgery or anesthesia in the next month or two (pulmonary aspiration risk)
- • History of diabetic retinopathy (for patients with type 2 diabetes)
- • Kidney problems with a history of severe dehydration
Side Effects: What's Similar, What's Different
Answer: Both share the GLP-1 class side-effect profile — nausea, diarrhea, vomiting, constipation — and an FDA boxed warning for thyroid C-cell tumors. Foundayo had higher overall GI event rates in trials (60–69% vs about 56% on Zepbound). Zepbound has injection site reactions in up to 8% of patients. Foundayo's label includes a tachycardia/heart-rate signal worth noting.
Side Effects in Common
- •Nausea (most common): ~35% on Foundayo at the highest dose; 25–33% on Zepbound
- •Diarrhea, constipation, vomiting — common on both, usually worst during early weeks and dose increases
- •Abdominal pain, indigestion, GERD, belching — common on both
- •Hair loss — reported on both, more notable in Foundayo trials
- •Fatigue — common on both, especially early
- •Decreased appetite — this is the mechanism, not a side effect, but it can be intense
Side Effects Unique to Each
Foundayo-specific
- • Higher overall GI event rate (60–69% vs 37% on placebo)
- • No injection site reactions
- • Tachycardia signal: 3% of Foundayo patients vs 1% on placebo; mean heart rate increase ~4–5 bpm
- • Newer drug, less long-term real-world data
Zepbound-specific
- • Injection site reactions in up to 8% (redness, itching, bruising)
- • Small resting heart rate increase in some patients
- • About 2.5 years of U.S. use since FDA approval (Nov 2023)
Discontinuation Rates
| GI-related discontinuation | All-cause adverse-reaction discontinuation | |
|---|---|---|
| Foundayo (5.5, 9, 17.2 mg) | 3%, 6%, 6% | 6%, 9%, 10% |
| Zepbound (higher doses) | ~1.9%, 3.3%, 4.3% | 4.8%, 6.3%, 6.7% |
Foundayo's discontinuation rates run somewhat higher than Zepbound's, especially for all-cause reasons. Both are in single digits at commonly used doses.
⚠️ Boxed Warning (Both Drugs)
Other warnings on both labels include acute pancreatitis, severe gastrointestinal reactions, acute kidney injury from dehydration, hypoglycemia, serious hypersensitivity reactions, acute gallbladder disease, and pulmonary aspiration during general anesthesia or deep sedation.
Foundayo post-marketing safety requirements
How Does Orforglipron Compare With Tirzepatide?
Answer: Orforglipron (Foundayo) is a small-molecule, non-peptide drug — built in a lab, which is why it survives stomach acid and can be a pill. Tirzepatide (Zepbound) is a peptide that activates two hormone receptors (GIP and GLP-1) at once, which produces more weight loss but requires injection and has stricter storage rules.
Peptide drugs like tirzepatide are essentially strings of proteins. Your stomach treats proteins like food and breaks them apart — that's why these drugs are injected. Small molecules like orforglipron are tiny chemical structures that survive stomach acid and don't need refrigeration. The mechanism difference is the big one: tirzepatide pulls on two pathways (GIP and GLP-1), orforglipron pulls only on GLP-1. Two pathways do more than one.
Storage — The Detail That Affects Real Life
Foundayo storage
Room temperature, 68°F to 77°F. Excursions to 59°F–86°F permitted. Keep in the original bottle and carton to protect from light. No refrigeration needed.
Zepbound storage
Refrigerate normally. Single-dose pens and vials: up to 21 days unrefrigerated. Unopened multi-dose vials and KwikPens: up to 30 days at room temperature. Once a KwikPen is in use: discard after 30 days, 30 days after first use, or after 4 weekly doses — whichever comes first.
Insurance, Prior Authorization, and What to Do If Denied
Answer: Roughly 43% of large employer plans (5,000+ employees) covered GLP-1s for weight loss as of 2025, almost always with prior authorization. Medicare currently excludes weight-loss drugs, with the July 2026 Medicare GLP-1 Bridge as the first major exception. If your plan denies, you have appeal rights and a cash-pay backup through LillyDirect.
What Prior Authorization Typically Requires
- BMI 30+, or BMI 27+ with a weight-related condition like type 2 diabetes, high blood pressure, or high cholesterol
- Documentation of previous lifestyle attempts that didn't produce adequate weight loss
- For Zepbound: a documented moderate-to-severe sleep apnea diagnosis can unlock coverage through the OSA pathway on plans that don't cover weight loss drugs
- A doctor's letter of medical necessity if the plan initially denies
The process typically takes 2–3 weeks on a friendly plan and 6+ weeks if denials and appeals get involved.
What to Do If Your Plan Denies Coverage
Get the specific reason in writing
Plans are required to provide this.
Submit a formal appeal
With a letter of medical necessity from your prescriber.
If the denial holds
Cash through LillyDirect at the prices above, or a different medication your plan does cover.
Where Ro's Insurance Concierge Actually Earns Its Fee
The $149/month membership covers a team that submits prior authorization paperwork on your behalf, follows up when paperwork stalls, writes appeal letters when your plan denies, and switches your prescription to a covered alternative if appeals don't work. For someone with a job and zero interest in spending hours on the phone with their insurer, that's worth $149/month for a few months even if you could theoretically get the same prescription cheaper somewhere else.
Skip Ro if:
- • You already have a doctor prescribing GLP-1s and your plan is friendly
- • You qualify for LillyDirect direct pricing and don't need help
- • You have Medicare or Medicaid (Ro's concierge can't navigate government plans for weight loss coverage)
Where to Actually Get Foundayo or Zepbound Online
Answer: Your options are LillyDirect direct (cheapest medication-only path if you have an existing prescriber), Ro (best for insurance navigation), or Sesame Care (best for provider choice with a lower flat monthly fee). Both Ro and Sesame Care currently carry Foundayo, Zepbound KwikPen, and Zepbound vials.
| LillyDirect | Ro | Sesame Care | |
|---|---|---|---|
| Foundayo available | Yes | Yes | Yes |
| Zepbound KwikPen available | Yes | Yes | Yes |
| Zepbound vials available | Yes (Self Pay Journey) | Yes | Yes |
| Monthly fee | None (medication only) | $39 first month, then $149/month or $74/month annual | $59–$99/month |
| Insurance navigation | None | Full concierge (PA, appeals) | Provider helps with paperwork |
| Free coverage check before signup | No | Yes (GLP-1 Insurance Coverage Checker) | No |
| Provider visits included | No (need your own prescriber) | Yes (monthly check-ins) | Yes (video visit included) |
| Pick your own provider | No | No (assigned) | Yes |
Our take
For most people comparing Foundayo vs Zepbound with commercial insurance, Ro is the strongest starting point because the free GLP-1 Insurance Coverage Checker tells you what your plan covers before you pay anything, and the insurance concierge handles the prior auth work that's the single biggest friction point.
Sesame Care is a strong alternative if you want to pick your own provider and pay a lower flat fee. Their pricing is straightforward — $99/month, or $59/month with annual. They carry the same drugs.
LillyDirect direct is the right path if you already have a doctor and just need the cheapest medication-only cost.
What Real Users Say
Foundayo only became available on April 6, 2026, so a body of long-term real-patient experience doesn't exist yet. What does exist is public discussion on Reddit, where Zepbound users are actively wrestling with whether to switch:
"The reduced price sure makes that tempting, though my shots have been life altering for me so I'm leery about changing course."— r/Zepbound user, Foundayo Maintenance? thread, accessed May 13, 2026
"I honestly prefer once a week over a daily medication, I just want to save money lol."— r/Zepbound user, same thread, accessed May 13, 2026
"Yeah I think framing it as a pill version of zepbound would be misleading."— r/Zepbound user, Pill version of zepbound thread, accessed May 13, 2026
These are real public quotes from people in the middle of this decision. They're voice-of-customer data, not medical evidence, and they don't predict your results.
What We Actually Verified
Direct verification on :
What we couldn't verify for your specific case: your insurance formulary, your prior authorization outcome, your state availability, your medical eligibility, taxes, shipping, or your real out-of-pocket cost. Those depend on you. The provider links above are the fastest way to get specific answers.
Last verified . We re-check the prices, FDA status, and provider terms on this page monthly because all of them change.
This page was created by the Weight Loss Provider Guide team — an independent comparison resource for GLP-1 telehealth providers. We compare FDA-approved brand-name medications (Foundayo, Zepbound, Wegovy, Ozempic, Mounjaro, Rybelsus) and the telehealth providers that prescribe them. We do not lead with compounded medications on FDA-approved brand-name comparison pages. We may earn affiliate commissions from some provider links on this page. Our rankings reflect our methodology — verified pricing, FDA status, fit for the reader's situation, and editorial judgment — not affiliate payouts.
Editorial note: This page is informational. It is not medical advice. Foundayo and Zepbound are prescription medications with serious warnings, including a boxed warning for thyroid C-cell tumors. Talk to a licensed prescriber about your specific health situation before starting, stopping, or switching any medication.
Related guides
- Best Foundayo providers — who carries it, pricing, and how to get it
- Foundayo vs Wegovy pill — the two oral GLP-1 options compared
- Foundayo cost with insurance — savings cards, prior auth, real math
- Best GLP-1 pill for PCOS — Foundayo vs Wegovy pill for PCOS situations
- GLP-1 medication storage guide — all major brands including Foundayo and Zepbound
- All GLP-1 provider reviews
Foundayo vs Zepbound: FAQ
Still not sure which GLP-1 program is right for you?
We'll ask you a few questions about your insurance, budget, medication preferences, and goals — then match you to the best-fit GLP-1 program for your exact situation. No commitment, no cost, no spam. Just clarity.
Take the free 60-second matching quiz